Related Experiment Video
Updated: Aug 8, 2026

A Novel High-resolution In vivo Imaging Technique to Study the Dynamic Response of Intracranial Structures to Tumor Growth and Therapeutics
Published on: June 16, 2013
Drug-radiation interactions in tumor blood vessels
D E Hallahan1, A Y Chen, M Teng
1Department of Biomedical Engineering, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Abstract:
Obliteration of the tumor vasculature is an effective means of achieving tumor regression. Antiangiogenic agents have begun to enter cancer clinical trials. Ionizing radiation activates the inflammatory cascade and increases the procoagulative state within blood vessels of both tumors and normal tissues. These responses are mediated through oxidative injury to the endothelium, leading to induction of cell-adhesion molecules and exocytosis of stored proteins from the endothelial cytoplasm. Agents that activate homeostatic responses in the endothelium can enhance thrombosis and vasculitis of irradiated tumor blood vessels. Proinflammatory and prothrombotic biological response modifiers given concurrently with ionizing radiation are known to induce vascular obliteration and necrosis of tumors. Other mechanisms of interaction between antiangiogenic agents and ionizing radiation include the direct cytotoxic effects of these agents. Interactions between drugs and radiation therapy might therefore occur at the level of the vascular endothelium. The importance of this paradigm is that the endothelium might not develop resistance to drugs or radiation because of lessened potential for mutagenesis and clonogenesis. The future design of clinical trials must consider the effects of radiation therapy on the vascular endothelium.
Insights
Tumor blood vessel destruction aids tumor regression. Combining antiangiogenic drugs with radiation therapy enhances this effect by targeting the tumor endothelium, potentially overcoming treatment resistance.
Area of Science:
- Oncology
- Vascular Biology
- Radiation Oncology
Background:
- Tumor vasculature obliteration is crucial for tumor regression.
- Antiangiogenic agents are emerging in cancer clinical trials.
- Ionizing radiation induces inflammation and a procoagulative state in tumor blood vessels.
Purpose of the Study:
- To explore the interactions between antiangiogenic agents and ionizing radiation.
- To investigate the role of the vascular endothelium in combined treatment efficacy.
- To understand mechanisms that may prevent resistance to cancer therapies.
Main Methods:
- Review of mechanisms of interaction between antiangiogenic agents and ionizing radiation.
- Analysis of endothelial responses to radiation, including oxidative injury and inflammatory cascade.
- Examination of how biological response modifiers affect irradiated tumor vasculature.
Main Results:
- Radiation induces endothelial oxidative injury, promoting procoagulative and inflammatory responses.
- Concurrent administration of proinflammatory and prothrombotic agents with radiation can cause vascular obliteration and tumor necrosis.
- Interactions may occur at the vascular endothelium level, potentially mitigating resistance.
Conclusions:
- The vascular endothelium is a key target for combined antiangiogenic and radiation therapies.
- Targeting endothelial responses may offer a strategy to enhance tumor regression and overcome resistance.
- Future clinical trial designs should incorporate the impact of radiation on the vascular endothelium.
More Related Videos
Related Concept Videos
The Tumor Microenvironment
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Tumor Immunotherapy
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...

